Hans Yssel Selected Research

Hans Yssel Research Topics

Disease

10	Infections 09/2020 - 03/2009
8	Inflammation (Inflammations) 01/2019 - 04/2007
5	COVID-19 01/2022 - 01/2020
3	Zika Virus Infection 01/2021 - 01/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 12/2019
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017 - 04/2007
2	Virus Diseases (Viral Diseases) 01/2019 - 01/2017
2	Crohn Disease (Crohn's Disease) 04/2016 - 07/2015
2	Dermatitis 01/2016 - 03/2009
1	Common Cold 01/2022
1	Colitis 08/2021
1	Reinfection 01/2021
1	Disease Progression 01/2020
1	Arbovirus Infections 01/2019
1	Fatty Liver 01/2016
1	Erythema 01/2016
1	Necrosis 07/2015
1	Arthritis (Polyarthritis) 10/2013
1	Rheumatoid Arthritis 10/2013
1	Fibrosis (Cirrhosis) 07/2012
1	Systemic Scleroderma (Systemic Sclerosis) 07/2012
1	Melanoma (Melanoma, Malignant) 10/2011
1	Bites and Stings (Sting) 10/2011
1	Asthma (Bronchial Asthma) 06/2010
1	Hypersensitivity (Allergy) 06/2010
1	Atopic Dermatitis (Atopic Eczema) 04/2007
1	HIV Infections (HIV Infection) 01/2007
1	Fever (Fevers) 11/2006
1	Allergic Contact Dermatitis 08/2006

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2021 - 07/2002
5	Antiviral Agents (Antivirals)IBA 04/2019 - 10/2011
4	AntigensIBA 01/2022 - 07/2002
4	Interleukin-17 (Interleukin 17)IBA 01/2017 - 06/2008
3	AntibodiesIBA 01/2022 - 09/2020
3	VaccinesIBA 01/2021 - 01/2017
3	Interleukin-22 (IL-22)IBA 01/2017 - 01/2007
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 04/2019 - 01/2011
2	InterferonsIBA 04/2019 - 03/2016
2	Chemokine ReceptorsIBA 01/2018 - 04/2005
2	Imiquimod (Aldara)FDA LinkGeneric 01/2017 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 07/2015 - 08/2006
2	Interleukin-2 (IL2)IBA 08/2006 - 07/2002
1	Immunoglobulin M (IgM)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Dextran SulfateIBA 08/2021
1	Therapeutic UsesIBA 08/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Interferon-betaIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	LigandsIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Natural Killer Cell ReceptorsIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Estrogens (Estrogen)FDA Link 12/2019
1	ChemokinesIBA 09/2019
1	IsotopesIBA 04/2019
1	Amino Acids FDA Link 04/2019
1	Explosive Agents (Explosives)IBA 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2018
1	dodecanedioic acidIBA 01/2018
1	AcidsIBA 01/2018
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2018
1	LysophospholipidsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	SphingomyelinsIBA 01/2018
1	CeramidesIBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	PhosphatidylserinesIBA 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017
1	Interleukin-13IBA 04/2016
1	3-methyladenineIBA 09/2015
1	torinIBA 09/2015
1	InterleukinsIBA 07/2015
1	InflammasomesIBA 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2012
1	eIF-2 Kinase (eIF 2 Kinase)IBA 10/2011
1	Ribonucleases (Ribonuclease)IBA 10/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2011
1	CecropinsIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	Calcium Channels (Calcium Channel)IBA 06/2010
1	OvalbuminIBA 06/2010
1	CalciumIBA 06/2010
1	DihydropyridinesIBA 06/2010
1	aluminum sulfate (alum)IBA 06/2010
1	CEACAM1 ProteinIBA 03/2009
1	Oncostatin MIBA 04/2007
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2007
1	Metalloproteases (Metalloproteinases)IBA 11/2006
1	NickelIBA 08/2006
1	Interferon-gamma (Interferon, gamma)IBA 08/2006

Therapy/Procedure

1	Therapeutics 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Intradermal Injections 01/2016
1	Intranasal Administration 06/2010